Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00097903
Recruitment Status : Completed
First Posted : December 2, 2004
Last Update Posted : September 25, 2017
Information provided by (Responsible Party):
BioNumerik Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : May 2013